FDA Approval Activities for this Drug…

Adenoscan (Adenosine) Injection, Fujisawa Healthcare, NDA 20-059/S7 8/31/01 11/5/01 11/5/01 11/7/01 Adenoscan Indications: Adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Adenosine Injection, 3 mg/mL, Sicor ANDA 76-564 9/23/03 Adenosine Injection, 3 mg/mL, Baxter Healthcare ANDA 76-500 5/14/03 Adenosine Injection, 3 mg/mL, Baxter Healthcare ANDA 76-501 5/14/03 Adenosine Injection, 3 mg/mL, 2 mL & 4 mL, Bedford ANDA 76-404 | Adenosine Injection, American Pharma, Approval

For the latest approval information, please locate this drug using this index.